Connect with us

Stock News

Ascendis Pharma’s stock surges after FDA approval for first and only treatment for rare disease

Published

on


The stock of Ascendis Pharma A/S jumped 11% early Monday, after the biotech said the U.S. Food and Drug Administration has approved its Yorvipath as the first and only treatment for a rare endocrine disease.

Continue Reading

Stock News

Why investors should be worried about the market’s ‘invincibility syndrome’

Published

on


Too much optimism means there aren’t many left to buy stocks, says hedge fund manager.

Continue Reading

Stock News

Amex sees 6% growth in spending, and its stock heads higher

Published

on


The company says new member benefits are resonating with younger generations.

Continue Reading

Stock News

America is doing better than the media or our politicians tell us. Here’s proof.

Published

on


Washington, D.C. doesn’t work. You know what does? America itself.

Continue Reading

Trending